News
Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.
4mon
Zacks Investment Research on MSNNevro Stock May Gain on the CE Mark Certification for HFX iQNevro Corp. NVRO recently received CE Mark Certification in Europe for its HFX iQ spinal cord stimulation (SCS) system. The company can now market HFX iQ in all countries that recognize this ...
5d
Zacks.com on MSNGMED Stock May Benefit Following the Acquisition of NevroGMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers ...
Hosted on MSN2mon
Here's Why you Should Add Nevro Stock to Your Portfolio NowNevro NVRO is well-poised for growth in ... However, concerns regarding softness in the spinal cord stimulation (SCS) market and dependence on third-party payers persist. This Zacks Rank #2 ...
Nevro Corp. filed a notice of data breach with the Attorney General of Texas after discovering that information in the ...
Spinal cord stimulation offers relief for patients who have not responded to other treatments for chronic neuropathic pain. Spinal cord stimulation devices reduce the need for opioid-based pain ...
a system that uses spinal cord stimulation synced with so-called "rehabilitation robotics" to restore natural, coordinated movement to people with spinal cord injuries. The announcement coincided ...
Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.
Nevro’s comprehensive HFX spinal cord stimulation (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic ...
Nevro NVRO is well-poised for growth in ... However, concerns regarding softness in the spinal cord stimulation (SCS) market and dependence on third-party payers persist. This Zacks Rank #3 ...
Nevro’s comprehensive HFX™ spinal cord stimulation (SCS) platform includes the Senza® SCS system and support services for the treatment of chronic pain of the trunk and limb and painful ...
The acquisition of Nevro further expands Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results